Results of this study showed that HON has a higher docking score than Phosphomethylphosphonic acid guanylate ester to bind FGFR2; however, HON has been shown to inhibit FGFR signaling in lung squamous cell carcinoma (57). The gene discussed is FGFR2; the disease is squamous cell lung carcinoma.